Literature DB >> 9529132

The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions--comparison to other cytokines and growth factors.

J Ratajczak1, Q Zhang, E Pertusini, B S Wojczyk, M A Wasik, M Z Ratajczak.   

Abstract

The role of insulin (INS), and insulin-like growth factor-I (IGF-I) in the regulation of human erythropoiesis is not completely understood. To address this issue we employed several complementary strategies including: serum free cloning of CD34+ cells, RT-PCR, FACS analysis, and mRNA perturbation with oligodeoxynucleotides (ODN). In a serum-free culture model, both INS and IGF-I enhanced survival of CD34+ cells, but neither of these growth factors stimulated their proliferation. The influence of INS and IGF-I on erythroid colony development was dependent on a combination of growth factors used for stimulating BFU-E growth. When BFU-E growth was optimally stimulated with erythropoietin (EpO) + kit ligand (KL) the large erythroid colonies developed normally even in the absence of INS or IGF-I. However, the addition of both of these growth factors slightly enhanced colony size. On the other hand, if erythroid colonies were stimulated suboptimally with EpO + IL-3 only, INS or IGF-I increased the number of small erythroid bursts by approximately 30%. Both INS and IGF-I activated signal transduction in maturing human erythropoietic cells as determined by phosphorylation of the insulin receptor substrate-2 (IRS-2) protein. We also found by RT-PCR that mRNA coding for INS-R is expressed in FACS sorted CD34+, c-kit-R+ marrow cells, and in cells isolated from BFU-E and CFU-GM colonies. Expression of INS-R protein on these cells was subsequently confirmed by cytofluorometry. In contrast, the receptor for insulin-like growth factor-I (IGF-IR) was not detected on CD34+ cells, and was first easily detectable on more differentiated cells derived from day 6 BFU-E and CFU-GM colonies. We conclude that INS and IGF-I may be survival factors for human CD34+ cells, but are not required during early erythropoiesis. In contrast, both growth factors may play some role at the final stages of erythroid maturation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529132     DOI: 10.1038/sj.leu.2400927

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  32 in total

1.  Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV.

Authors:  M Majka; T Rozmyslowicz; B Lee; S L Murphy; Z Pietrzkowski; G N Gaulton; L Silberstein; M Z Ratajczak
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Association between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasis.

Authors:  Flaviane Alves de Pinho; Célia Maria Vieira Vendrame; Bruna Leal Lima Maciel; Lucilene Dos Santos Silva; Samantha Ive Miyashiro; Selma Maria Bezerra Jerônimo; Hiro Goto
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

3.  Reduced number of VSELs in the bone marrow of growth hormone transgenic mice indicates that chronically elevated Igf1 level accelerates age-dependent exhaustion of pluripotent stem cell pool: a novel view on aging.

Authors:  M Kucia; D-M Shin; R Liu; J Ratajczak; E Bryndza; M M Masternak; A Bartke; M Z Ratajczak
Journal:  Leukemia       Date:  2011-05-13       Impact factor: 11.528

Review 4.  In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.

Authors:  Zbigniew Darzynkiewicz; Hong Zhao; H Dorota Halicka; Jiangwei Li; Yong-Syu Lee; Tze-Chen Hsieh; Joseph M Wu
Journal:  Cytometry A       Date:  2014-02-22       Impact factor: 4.355

5.  The negative effect of prolonged somatotrophic/insulin signaling on an adult bone marrow-residing population of pluripotent very small embryonic-like stem cells (VSELs).

Authors:  Magda Kucia; Michal Masternak; Riu Liu; Dong-Myung Shin; Janina Ratajczak; Katarzyna Mierzejewska; Adam Spong; John J Kopchick; Andrzej Bartke; Mariusz Z Ratajczak
Journal:  Age (Dordr)       Date:  2012-01-05

6.  Higher number of stem cells in the bone marrow of circulating low Igf-1 level Laron dwarf mice--novel view on Igf-1, stem cells and aging.

Authors:  J Ratajczak; D-M Shin; W Wan; R Liu; M M Masternak; K Piotrowska; B Wiszniewska; M Kucia; A Bartke; M Z Ratajczak
Journal:  Leukemia       Date:  2011-01-14       Impact factor: 11.528

7.  Detection of protein tyrosine-kinase (PTK) gene expression pattern in normal and malignant T lymphocytes by combined PTK-specific polymerase chain reaction and parallel denaturing gradient gel electrophoresis.

Authors:  Zhi-Yong Wang; Qian Zhang; John Wilson; Mariusz Z Ratajczak; Mariusz A Wasik
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

8.  Thermal injury of the skin induces G-CSF-dependent attenuation of EPO-mediated STAT signaling and erythroid differentiation arrest in mice.

Authors:  John G Noel; Benjamin J Ramser; Jose A Cancelas; Francis X McCormack; Jason C Gardner
Journal:  Exp Hematol       Date:  2017-09-01       Impact factor: 3.084

9.  Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.

Authors:  Michele P Lambert; Lubica Rauova; Matthew Bailey; Martha C Sola-Visner; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

10.  Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro.

Authors:  Andrea E Wahner Hendrickson; Paul Haluska; Paula A Schneider; David A Loegering; Kevin L Peterson; Ricardo Attar; B Douglas Smith; Charles Erlichman; Marco Gottardis; Judith E Karp; Joan M Carboni; Scott H Kaufmann
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.